Cite

HARVARD Citation

    Propper, D. et al. (2016). Phase II study of TP300 in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma. BMC cancer. 16 (1), pp. 1-7. [Online]. 
  
Back to record